T2 Biosystems Inc. [NASDAQ: TTOO] jumped around 0.7 points on Friday, while shares priced at $3.10 at the close of the session, up 29.17%. The company report on February 4, 2021 that T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Brazil P.1 Variant of the SARS-CoV-2 Virus.
Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence alignments and in silico analysis.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced that its T2SARS-CoV-2™ Panel—a molecular diagnostic test that detects SARS-CoV-2, the virus responsible for COVID-19 infections—is capable of detecting the Brazil (P.1) variant of the SARS-CoV-2 virus, which was recently confirmed to be present in the United States.
T2 Biosystems Inc. stock is now 150.00% up from its year-to-date (YTD) trading value. TTOO Stock saw the intraday high of $3.45 and lowest of $2.9389 per share. The company’s 52-week high price is 2.92, which means current price is +160.50% above from all time high which was touched on 02/05/21.
Compared to the average trading volume of 9.15M shares, TTOO reached a trading volume of 82473729 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about T2 Biosystems Inc. [TTOO]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TTOO shares is $3.18 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TTOO stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Alliance Global Partners have made an estimate for T2 Biosystems Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 27, 2021. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on October 08, 2020, representing the official price target for T2 Biosystems Inc. stock.
The Average True Range (ATR) for T2 Biosystems Inc. is set at 0.32, with the Price to Sales ratio for TTOO stock in the period of the last 12 months amounting to 26.50. The Price to Book ratio for the last quarter was 25.83, with the Price to Cash per share for the same quarter was set at 0.36.
How has TTOO stock performed recently?
T2 Biosystems Inc. [TTOO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 55.78. With this latest performance, TTOO shares gained by 134.85% in over the last four-week period, additionally plugging by 87.88% over the last 6 months – not to mention a rise of 257.51% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TTOO stock in for the last two-week period is set at 75.22, with the RSI for the last a single of trading hit 78.09, and the three-weeks RSI is set at 73.41 for T2 Biosystems Inc. [TTOO]. The present Moving Average for the last 50 days of trading for this stock 1.52, while it was recorded at 2.43 for the last single week of trading, and 1.33 for the last 200 days.
T2 Biosystems Inc. [TTOO]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and T2 Biosystems Inc. [TTOO] shares currently have an operating margin of -624.57 and a Gross Margin at -101.12. T2 Biosystems Inc.’s Net Margin is presently recorded at -707.93.
Additionally, TTOO Total Debt to Total Capital is recorded at 366.64, with Total Debt to Total Assets ending up at 164.14.
Reflecting on the efficiency of the workforce at the company, T2 Biosystems Inc. [TTOO] managed to generate an average of -$390,768 per employee. Receivables Turnover for the company is 3.62 with a Total Asset Turnover recorded at a value of 0.18.T2 Biosystems Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.60 and a Current Ratio set at 5.00.
Earnings analysis for T2 Biosystems Inc. [TTOO]
With the latest financial reports released by the company, T2 Biosystems Inc. posted -0.29/share EPS, while the average EPS was predicted by analysts to be reported at -0.27/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -7.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TTOO.
Insider trade positions for T2 Biosystems Inc. [TTOO]
There are presently around $56 million, or 12.70% of TTOO stock, in the hands of institutional investors. The top three institutional holders of TTOO stocks are: VANGUARD GROUP INC with ownership of 5,364,440, which is approximately 12.706% of the company’s market cap and around 0.10% of the total institutional ownership; GOLDMAN SACHS GROUP INC, holding 4,358,817 shares of the stock with an approximate value of $13.51 million in TTOO stocks shares; and BLACKROCK INC., currently with $6.83 million in TTOO stock with ownership of nearly 0.023% of the company’s market capitalization.
Positions in T2 Biosystems Inc. stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 37 institutional holders increased their position in T2 Biosystems Inc. [NASDAQ:TTOO] by around 3,046,938 shares. Additionally, 18 investors decreased positions by around 1,206,576 shares, while 15 investors held positions by with 13,755,046 shares. The mentioned changes placed institutional holdings at 18,008,560 shares, according to the latest SEC report filing. TTOO stock had 16 new institutional investments in for a total of 705,134 shares, while 9 institutional investors sold positions of 675,656 shares during the same period.